SafePAS key facts
as of Oct 2026- Developer of an AI-based portable analytical sensor designed to provide rapid, accurate, and cost-effective testing for medical and agricultural needs.
- SafePAS is valued at approximately $6.6M as of Oct 2026 (last reported valuation).
- It has raised $950K.
- Notable investors include European Innovation Council, European Commission, Teamworthy Group, BSV Ventures, Beamline — 11 tracked in total.
- Status: Privately Held (backing).
SafePAS's last reported valuation, Jun 2025. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch SafePAS: the Monday email on marks, rounds and moves
SafePAS funding rounds
No funding rounds for SafePAS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs SafePAS
11+SafePAS valuation
SafePAS's last reported valuation was $6.6 million in Jun 2025. No priced round, secondary trade or fund mark has surfaced since.
SafePAS investors
11 investors are on record for SafePAS, including European Innovation Council, European Commission, Teamworthy Group and BSV Ventures.
About SafePAS
Developer of an AI-based portable analytical sensor designed to provide rapid, accurate, and cost-effective testing for medical and agricultural needs. The company offers advanced, highly sensitive devices that deliver lab-quality quantitative analysis at significantly reduced costs, enabling healthcare providers, law enforcement agencies, and farmers to make informed decisions quickly and efficiently in diverse environments.
- Sector
- Healthcare
- HQ
- Tallinn, Estonia
- Employees
- 15
- Website
- safepas.eu/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.